Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
£ 42
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is underpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only
Buy
Sell